发明名称 Use of the modified polysaccharides for heparin neutralization
摘要 The subject of the invention is the use of cationically modified polysaccharides, except for chitosan, for direct neutralization of heparin in blood and physiological fluids in a mammal. Cationic modification of the polysaccharides is achieved using compound containing cationic ammonium groups and/or the polysaccharides are grafted with a polymer containing amine and/or ammonium groups.
申请公布号 US9504707(B2) 申请公布日期 2016.11.29
申请号 US201113642279 申请日期 2011.04.20
申请人 UNIWERSYTET JAGIELLONSKI 发明人 Nowakowska Maria;Szczubiałka Krzysztof;Kamiński Kamil
分类号 A61K31/717;A61K31/721 主分类号 A61K31/717
代理机构 Walker & Jocke 代理人 Walker & Jocke
主权项 1. A method of direct neutralization of unfractionated heparin in blood and physiological fluids comprising intravenously administering to a mammal in need thereof cationically modified polysaccharides comprising hydroxypropyl cellulose grafted with N-acrylamidopropyl-N,N,N-trimethylammonium chloride.
地址 Crakow PL